PR Newswire BiotechnologyCodex · 实盘不做把握 8/10
北京时间·🕒 发布 03:00:00时区推断·⟳ 抓取 03:01:13·⚡ 决策 07-30 03:02:15 +1m02s·89.7 天前
Greenberg Traurig宣传其为Entera Bio 2.75亿美元PIPE融资提供法律顾问
本条新增事实是律所宣传其法律顾问角色，不是Entera Bio新的融资公告或临床进展。
📄 原文PR Newswire Biotechnology↗ 原文
Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE
MIAMI, July 29, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Entera Bio Ltd. (NASDAQ: ENTX), a…
不做 Entera Bio（ENTX.US）
不做：本条是律所品牌宣传和旧融资复述，核心2.75亿美元PIPE融资已在2026-07-27由公司官方公告并被市场交易，当前无新增可交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- Entera Bio已正式公告2.75亿美元超额认购PIPE融资、每股2.04美元、资金支持EB613 Phase 3并延长现金 runway 至2030年。
- 财经媒体在7月27日美股开盘前后已报道该融资核心事实，说明消息并非7月29日新鲜首发。市场反应:同源页面显示ENTX相关行情已有大幅同向反应。
- 媒体报道Entera Bio股价因2.75亿美元PIPE融资跳涨，证明核心融资催化已被交易。市场反应:报道称ENTX在融资公告后显著上涨。
- 本次信号只是Greenberg Traurig宣传其为该融资提供法律服务，未披露新的融资条款、临床进展或经营增量。
关键理由
- 本条新增事实是律所宣传其法律顾问角色，不是Entera Bio新的融资公告或临床进展。
- 2.75亿美元PIPE融资本身已由Entera Bio在2026-07-27官方披露，并已被财经媒体报道和股价反应消化。
- 当前19:00 UTC信号距融资首发已约两天，只剩二次传播/品牌宣传属性，无法形成新的同向交易edge。
主要风险
- 若后续公司另行披露融资交割失败、条款重大变化或EB613临床节点，需按新事件重判。
原文全文
展开原文 · 1,802 字
MIAMI, July 29, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing.
The financing is expected to extend Entera Bio's cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH (1-34) peptide tablet in development for the treatment of osteoporosis, according to the company's press release.
This financing is the largest publicly disclosed Israeli biotech private investment in public equity (PIPE) on record and the ninth largest publicly disclosed Israeli PIPE transaction across all industries, according to data compiled by Arx Capital Markets, Entera Bio's investor relations firm.
The Greenberg Traurig team representing Entera Bio in this transaction was led by MiamiCorporate Practice Co-Chair Drew M. Altman and Miami Corporate Shareholder Sami B. Ghneim, with assistance from Miami Corporate Associate Angel A. Marcial and Tel-Aviv office Managing Shareholder Joey T. Shabot.
About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.
SOURCE Greenberg Traurig, LLP
The financing is expected to extend Entera Bio's cash runway into 2030 and fully support Phase 3 registrational studies for EB613, the first oral PTH (1-34) peptide tablet in development for the treatment of osteoporosis, according to the company's press release.
This financing is the largest publicly disclosed Israeli biotech private investment in public equity (PIPE) on record and the ninth largest publicly disclosed Israeli PIPE transaction across all industries, according to data compiled by Arx Capital Markets, Entera Bio's investor relations firm.
The Greenberg Traurig team representing Entera Bio in this transaction was led by MiamiCorporate Practice Co-Chair Drew M. Altman and Miami Corporate Shareholder Sami B. Ghneim, with assistance from Miami Corporate Associate Angel A. Marcial and Tel-Aviv office Managing Shareholder Joey T. Shabot.
About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.
SOURCE Greenberg Traurig, LLP
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。